Related Experiment Video
Updated: Oct 10, 2025

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
Breast Cancer: A Global Concern, Diagnostic and Therapeutic Perspectives, Mechanistic Targets in Drug Development
Gul-E-Saba Chaudhry1, Rehmat Jan2, Abdah Akim3
1Institute of Marine Biotechnology, University Malaysia Terengganu, 21030 Kuala Terengganu, Malaysia.
Abstract:
Cancer is a complex multifactorial process, unchecked and abrupt division, and cell growth-conventional chemotherapy, along with radiotherapy, is used to treat breast cancer. Due to reduce efficacy and less survival rate, there is a particular need for the discovery of new active anticancer agents. Natural resources such as terrestrial/marine plants or organisms are a promising source for the generation of new therapeutics with improving efficacy. The screening of natural plant extracts and fractions, isolations of phytochemicals, and mechanistic study of those potential compounds play a remarkable role in the development of new therapeutic drugs with increased efficacy. Cancer is a multistage disease with complex signaling cascades. The initial study of screening whole extracts or fractions and later the isolation of secondary compounds and their mechanism of action study gives a clue of potential therapeutic agents for future drug development. The phytochemicals present in extracts/fractions produce remarkable effects due to synergistically targeting multiple signals. In this review, the molecular targets of extracts/ fractions and isolated compounds highlighted. The therapeutic agent's mechanistic targets in drug development focused involves; i) Induction of Apoptosis, ii) modulating cell cycle arrest, iii) Inhibition or suppression of invasion and metastasis and iv) various other pro-survival signaling pathways. The phytochemicals and their modified analogs identified as future potential candidates for anticancer chemotherapy.
Insights
Natural compounds offer promising anticancer agents for breast cancer treatment, targeting key pathways like apoptosis and cell cycle arrest. Further research into phytochemicals and their analogs could lead to more effective chemotherapy drugs.
Area of Science:
- Oncology
- Pharmacology
- Natural Product Chemistry
Background:
- Conventional breast cancer treatments (chemotherapy, radiotherapy) face challenges with efficacy and patient survival rates.
- There is a critical need for novel anticancer agents with improved therapeutic potential.
- Natural resources, including plants and marine organisms, represent a rich source for discovering new drug candidates.
Purpose of the Study:
- To review the role of natural products, specifically phytochemicals, in the development of novel anticancer therapeutics.
- To highlight the molecular targets and mechanisms of action of plant extracts, fractions, and isolated compounds against cancer.
- To explore the potential of phytochemicals and their analogs as future candidates for anticancer chemotherapy.
Main Methods:
- Screening of natural plant extracts and fractions for anticancer activity.
- Isolation and characterization of bioactive phytochemicals from these extracts.
- Mechanistic studies to elucidate the molecular targets and pathways affected by these compounds.
Main Results:
- Phytochemicals demonstrate significant anticancer effects through synergistic targeting of multiple signaling pathways.
- Identified mechanisms include induction of apoptosis, modulation of cell cycle arrest, and inhibition of invasion and metastasis.
- Various pro-survival signaling pathways are also targeted by these natural compounds.
Conclusions:
- Natural products, particularly phytochemicals, show considerable promise as a source for developing new anticancer drugs.
- Understanding the molecular mechanisms of these compounds is crucial for their advancement into clinical applications.
- Phytochemicals and their modified analogs are identified as potential future candidates for effective breast cancer chemotherapy.
More Related Videos
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Treatment Resistant Cancers
Mitogens and the Cell Cycle
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: